Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease

• Published in: Hepatology (Baltimore, Md.) Vol. 76; no. 5; pp. 1409 - 1422
• Main Authors: Zhang, Xinrong, Wong, Grace Lai‐Hung, Yip, Terry Cheuk‐Fung, Cheung, Johnny T. K., Tse, Yee‐Kit, Hui, Vicki Wing‐Ki, Lin, Huapeng, Lai, Jimmy Che‐To, Chan, Henry Lik‐Yuen, Kong, Alice Pik‐Shan, Wong, Vincent Wai‐Sun
• Format: Journal Article
• Language: English
• Published: Hoboken Wolters Kluwer Health, Inc 01.11.2022
• Subjects: Age; Aspartate aminotransferase; Cirrhosis; Diabetes; Diabetes mellitus (non-insulin dependent); Fatty liver; Fibrosis; fibrosis scores; Hepatology; Liver cancer; Liver cirrhosis; Liver diseases; nonalcoholic steatohepatitis; Risk factors; type 2 diabetes mellitus

Background and Aims Several guidelines recommend screening for NAFLD in patients with type 2 diabetes (T2D). We aimed to determine if there is a threshold of age and duration of T2D for liver‐related event development to guide screening strategies. Approach and Results We conducted a territory‐wide...